Nandagopal R, Laverdière C, Mulrooney D, Hudson MM, Meacham L. Endocrine late effects of childhood cancer therapy: A report from the children’s oncology group. Horm Res. 2008;69(2):65-74. https://pubmed.ncbi.nlm.nih.gov/18059086. https://doi.org/10.1159/000111809.

Ostrom QT, De Blank PM, Kruchko C, et al. Alex’s Lemonade Stand Foundation infant and childhood primary brain and central nervous system tumour diagnosed in the United States in 2007-2011. Neuro Oncol. 2015;16(Suppl 10):x1-36. https://pubmed.ncbi.nlm.nih.gov/25542864. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277295. https://doi.org/10.1093/neuonc/nou327.

Azizah AM, Nor Saleha IT, Noor Hashimah A, Asmah Za, Mastulu W. Malaysia National Cancer Registry Report 2007-2011; 2015.

Takada A, Ii N, HIrayama M, et al. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor. J Neurosurg Pediatr. 2018;23(3):317-24. https://pubmed.ncbi.nlm.nih.gov/30497152. https://doi.org/10.3171/2018.9.PEDS18181.

Chemaitilly W, Cohen LE, Mostoufi-Moab S, et al. Endocrine late effects in childhood cancer survivors. J Clin Oncol. 2018;36(21):2153-9. https://pubmed.ncbi.nlm.nih.gov/29874130. https://doi.org/10.1200/JCO.2017.76.3268.

Merchant TE, Conklin HM, Wu S, Lustig RH, Xiong X. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: Prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol. 2009;27(22):3691-7. https://pubmed.ncbi.nlm.nih.gov/19581535. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799064. https://doi.org/10.1200/JCO.2008.21.2738.

Chemaitilly W, Li Z, Huang S, et al. Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: A report from St Jude Lifetime Cohort. J Clin Oncol. 2015;33(5):492-500. https://pubmed.ncbi.nlm.nih.gov/25559807. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314596. https:///doi.org/10.1200/JCO.2014.56.7933.

Ng YJ, Jalaludin MY, Foo JC, Qaddoumi I, Rajagopal R. Prevalence and risk factors for endocrine disorders in childhood brain tumors From a single tertiary center in Malaysia. J Pediatr Hematol Oncol. 2022;44(4):159-66. https://pubmed.ncbi.nlm.nih.gov/35446802. https://doi.org/10.1097/MPH.0000000000002447.

Clement SC, Schouten-van Meeteren AYN, Kremer LCM, van Trotsenburg ASP, Caron HN, van Santen HM. High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: Need for standardized follow-up programs. Pediatr Blood Cancer. 2014;61(12):2285-9. https://pubmed.ncbi.nlm.nih.gov/25131941. https://doi.org/10.1002/pbc.25176.

Heo J, Lee HS, Hwang JS, Noh OK, Kim L, Park JE. Prevalence of endocrine disorders in childhood brain tumor survivors in South Korea. In Vivo. 2019;33(6):2287-91. https://pubmed.ncbi.nlm.nih.gov/31662569. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899123. https://doi.org/10.21873/invivo.11735.

Clement, S. C. et al. Prevalence and risk factors of early endocrine disorders in childhood brain tumor survivors: A nationwide, multicenter study. J Clin Oncol. 216;34(36):4362-70. https://pubmed.ncbi.nlm.nih.gov/27998218. https://doi.org/10.1200/JCO.2016.67.5025.

Shaw S. Endocrine late effects in survivors of pediatric brain tumors. J Pediatr Oncol Nurs. 2009;26(5):295-302. https://pubmed.ncbi.nlm.nih.gov/19837959. https://doi.org/10.1177/1043454209343180.

Cohen LE, Gordon JH, Popovsky EY, et al. Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: High incidence of endocrine and growth problems. Bone Marrow Transplant. 2014;49(4):502-8. https://pubmed.ncbi.nlm.nih.gov/24442245. https://doi.org/10.1038/bmt.2013.218.

Patterson BC0, Wasilewski-Masker K, Ryerson AB0, Mertens A, Meacham L. Endocrine health problems detected in 519 patients evaluated in a pediatric cancer survivor program. J Clin Endocrinol Metab. 2012;97(3):810-8. https://pubmed.ncbi.nlm.nih.gov/22188743. https://doi.org/10.1210/jc.2011-2104.

Oberfield SE, Allen JC, Pollack J, New MI, Levine LS. Long-term endocrine sequelae after treatment of medulloblastoma. Prospective study of growth and thyroid function. J Paediatr. 1986;108(2):219-23. https://pubmed.ncbi.nlm.nih.gov/3944706. https://doi.org/10.1016/s0022-3476(86)80986-6.

Fang FY, Rosenblum JS, Ho WS, Heiss JD. New developments in the pathogenesis, therapeutic targeting, and treatment of pediatric medulloblastoma. Cancers (Basel). 2022;14(9):2285. https://pubmed.ncbi.nlm.nih.gov/35565414. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100249. https://doi.org/10.3390/cancers14092285.

Maciel J, Dias D, Cavaco D, Donato s, Pereira MC, Simões-Pereira MC. Growth hormone deficiency and other endocrinopathies after childhood brain tumors: Results from a close follow-up in a cohort of 242 patients. J Endocrinol Invest.2021;44(11):2367-74. https://pubmed.ncbi.nlm.nih.gov/33683662. https://doi.org/10.1007/s40618-021-01541-4.

Lone DW, Sadak KT, Miller BS, et al. Prevalence of childhood growth hormone deficiency in survivors of pediatric intracranial germ cell tumors. J Clin Oncol. 2022;12(3):79-88. https://pubmed.ncbi.nlm.nih.gov/36249955. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555288. https://doi.org/10.14740/jem807.

Lawson SA, Home VE, Golekoh MC, et al. Hypothalamic–pituitary function following childhood brain tumors: Analysis of prospective annual endocrine screening. Pediatr Blood Cancer. 2019;66(5):e27631.

Gurney JG, Ness KK, Stovall M, et al. Final height and body mass index among adult survivors of childhood brain cancer: Childhood cancer survivor study. J Clin Endocrinol Metab. 2003;88(10):4731-9. https://pubmed.ncbi.nlm.nih.gov/14557448. https://doi.org/10.1210/jc.2003-030784.

Pasqualini T, Diez B, Domene H, et al. Long-term endocrine sequelae after surgery, radiotherapy and chemotherapy in children with medulloblastoma. Cancer. 1987;59(4):801-6. https://pubmed.ncbi.nlm.nih.gov/3802038. https://doi.org/10.1002/1097-0142(19870215)59:4<801::aid-cncr2820590424>3.0.co;2-z.

Nyanti L, Samsudin A, Tiong IK. Syndrome of inappropriate antidiuretic hormone secretion and Leser-Trélat syndrome as uncommon paraneoplastic manifestations of renal malignancy - A geriatric experience: A case report. J Med Case Rep. 2019;13(1):188. https://pubmed.ncbi.nlm.nih.gov/31221202. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587240. https://doi.org/10.1186/s13256-019-2122-8.

Kumar MM, Foster JR, Sharan S, DeRibaupierre S, McKillop SJ, Kornecki A. Transient blindness as the primary symptom of acute hyponatremia post surgery. J Pediatr Intensive Care. 2013;1(3):169-72. https://pubmed.ncbi.nlm.nih.gov/31214404. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530693. https://doi.org/10.3233/PIC-2012-028.

Das UN. Obesity: Genes, brain, gut, and environment. Nutrition. 2010;26(5):459-73. https://pubmed.ncbi.nlm.nih.gov/20022465. https://doi.org/10.1016/j.nut.2009.09.020.

Mediavilla C. Bidirectional gut-brain communication: A role for orexin-A. Neurochem Int. 2020;141:104882. https://pubmed.ncbi.nlm.nih.gov/33068686. https://doi.org/10.1016/j.neuint.2020.104882.

Lutsig RH, Post SR, Merchant T. Risk factors for the development of obesity in children surviving brain tumour. J Clin Endocrinol Metab. 2003;88(2):611-6. https://pubmed.ncbi.nlm.nih.gov/12574189. https://doi.org/10.1210/jc.2002-021180.

Cooksey R, Wu SY, Bowers D, et al. Metabolic syndrome is a sequalae of radiation exposure in hypothalamic obesity among survivors of childhood brain tumours. J Investig Med. 2019;67(2):295-302. https://pubmed.ncbi.nlm.nih.gov/30530528. https://doi.org/10.1136/jim-2018-000911.

Yalçin B, Kremer LCM, van Dalen EC. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Cochrane Database Syst Rev.2015;2015(10):CD006301. https://pubmed.ncbi.nlm.nih.gov/26436598. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783746. https://doi.org/10.1002/14651858.CD006301.pub4.

Khanal N, Ahmed SS, Kalra M, et al. The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy. Support Care Cancer. 2020;28(7):3165-70. https://pubmed.ncbi.nlm.nih.gov/31707501. https://doi.org/10.1007/s00520-019-05117-0.

Zaid MA, Dinh PC, Monahan PO, et al. Adverse health outcomes in relationship to hypogonadism after chemotherapy: A multicenter study of testicular cancer survivors. J Natl Compr Canc Netw. 2019;17(5):459-68. https://pubmed.ncbi.nlm.nih.gov/31085753. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712564. https://doi.org/10.6004/jnccn.2018.7109.